苑东生物：关于自愿披露吡仑帕奈片获得药品注册证书的公告

Group 1 - The core point of the article is that Yuandong Biologics has received approval from the National Medical Products Administration for the drug registration certificate for Pirfenidone tablets [2] Group 2 - The announcement was made on the evening of September 5, indicating a significant regulatory milestone for the company [2] - The approval of the drug is expected to enhance the company's product portfolio and market presence [2] - This development may lead to potential revenue growth opportunities for Yuandong Biologics in the pharmaceutical market [2]